HOME / PUBLICATIONS /

Efficacy of canakinumab in patients with still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for still’s disease

Citation:

Vitale A, Caggiano V, Sfikakis PP, Dagna L, Lopalco G, Ragab G, La Torre F, Almaghlouth IA, Maggio MC, Sota J. Efficacy of canakinumab in patients with still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for still’s disease. Frontiers in Medicine 2023;10:1256243.